350 related articles for article (PubMed ID: 15837748)
1. Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer.
Irie A; Yamauchi A; Kontani K; Kihara M; Liu D; Shirato Y; Seki M; Nishi N; Nakamura T; Yokomise H; Hirashima M
Clin Cancer Res; 2005 Apr; 11(8):2962-8. PubMed ID: 15837748
[TBL] [Abstract][Full Text] [Related]
2. Galectin-9, a novel prognostic factor with antimetastatic potential in breast cancer.
Yamauchi A; Kontani K; Kihara M; Nishi N; Yokomise H; Hirashima M
Breast J; 2006; 12(5 Suppl 2):S196-200. PubMed ID: 16959001
[TBL] [Abstract][Full Text] [Related]
3. [Screening of a sub-clone of human breast cancer cells with high metastasis potential].
Ye LH; Wu LY; Guo W; Ma HT; Zhang XD
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):61-5. PubMed ID: 16606541
[TBL] [Abstract][Full Text] [Related]
4. Truncated galectin-3 inhibits tumor growth and metastasis in orthotopic nude mouse model of human breast cancer.
John CM; Leffler H; Kahl-Knutsson B; Svensson I; Jarvis GA
Clin Cancer Res; 2003 Jun; 9(6):2374-83. PubMed ID: 12796408
[TBL] [Abstract][Full Text] [Related]
5. DPD activity and immunohistochemical DPD expression in human breast cancer.
Horiguchi J; Yoshida T; Koibuchi Y; Iijima K; Ninomiya J; Takei H; Yokoe T; Iino Y; Morishita Y
Oncol Rep; 2004 Jan; 11(1):65-72. PubMed ID: 14654904
[TBL] [Abstract][Full Text] [Related]
6. Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
Azuma H; Ehata S; Miyazaki H; Watabe T; Maruyama O; Imamura T; Sakamoto T; Kiyama S; Kiyama Y; Ubai T; Inamoto T; Takahara S; Itoh Y; Otsuki Y; Katsuoka Y; Miyazono K; Horie S
J Natl Cancer Inst; 2005 Dec; 97(23):1734-46. PubMed ID: 16333029
[TBL] [Abstract][Full Text] [Related]
7. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.
Glinsky VV; Huflejt ME; Glinsky GV; Deutscher SL; Quinn TP
Cancer Res; 2000 May; 60(10):2584-8. PubMed ID: 10825125
[TBL] [Abstract][Full Text] [Related]
8. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
9. Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ.
Kurebayashi J; McLeskey SW; Johnson MD; Lippman ME; Dickson RB; Kern FG
Cancer Res; 1993 May; 53(9):2178-87. PubMed ID: 8481921
[TBL] [Abstract][Full Text] [Related]
10. SCUBE2 suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer.
Cheng CJ; Lin YC; Tsai MT; Chen CS; Hsieh MC; Chen CL; Yang RB
Cancer Res; 2009 Apr; 69(8):3634-41. PubMed ID: 19369267
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas.
Shimamura T; Sakamoto M; Ino Y; Shimada K; Kosuge T; Sato Y; Tanaka K; Sekihara H; Hirohashi S
Clin Cancer Res; 2002 Aug; 8(8):2570-5. PubMed ID: 12171885
[TBL] [Abstract][Full Text] [Related]
13. Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer.
Ricciardelli C; Brooks JH; Suwiwat S; Sakko AJ; Mayne K; Raymond WA; Seshadri R; LeBaron RG; Horsfall DJ
Clin Cancer Res; 2002 Apr; 8(4):1054-60. PubMed ID: 11948113
[TBL] [Abstract][Full Text] [Related]
14. Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease.
Kluger HM; Chelouche Lev D; Kluger Y; McCarthy MM; Kiriakova G; Camp RL; Rimm DL; Price JE
Cancer Res; 2005 Jul; 65(13):5578-87. PubMed ID: 15994930
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of a whole-body visualization model of breast cancer with high hepatic metastatic potential in nude mice through serial passage in vivo].
Yang M; Yang ZH; Hou ZD; Li XN
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):944-7. PubMed ID: 18583234
[TBL] [Abstract][Full Text] [Related]
16. Enhanced motility of KGF-transfected breast cancer cells.
Zang XP; Bullen EC; Manjeshwar S; Jupe ER; Howard EW; Pento JT
Anticancer Res; 2006; 26(2A):961-6. PubMed ID: 16619493
[TBL] [Abstract][Full Text] [Related]
17. Varied expression and localization of multiple galectins in different cancer cell lines.
Satelli A; Rao PS; Gupta PK; Lockman PR; Srivenugopal KS; Rao US
Oncol Rep; 2008 Mar; 19(3):587-94. PubMed ID: 18288388
[TBL] [Abstract][Full Text] [Related]
18. Down-regulated xanthine oxidoreductase is a feature of aggressive breast cancer.
Linder N; Lundin J; Isola J; Lundin M; Raivio KO; Joensuu H
Clin Cancer Res; 2005 Jun; 11(12):4372-81. PubMed ID: 15958620
[TBL] [Abstract][Full Text] [Related]
19. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.
Yee AJ; Akens M; Yang BL; Finkelstein J; Zheng PS; Deng Z; Yang B
Breast Cancer Res; 2007; 9(4):R47. PubMed ID: 17662123
[TBL] [Abstract][Full Text] [Related]
20. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]